COMMUNIQUÉS West-GlobeNewswire

AIT Therapeutics to Participate at Two Investor Conferences in March
13/03/2019
GARDEN CITY, N.Y., and REHOVOT, Israel, March 13, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ( [...]
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial Results
13/03/2019
WALTHAM, Mass., March 13, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular [...]
Tauriga Sciences Inc. Further Increases its Production of Tauri-Gum Inventory to Support its Ongoing Commercial Launch
13/03/2019
New York, NY, March 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]
Solid Biosciences Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update
13/03/2019
–Activities underway to commence dosing of second cohort of patients in the IGNITE DMD clinical trial at 2E14 vg/kg of SGT-001– CAMBRIDGE, Mass., March 13, 2019 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ: SLDB) [...]
KemPharm Provides Update on APADAZ® Formulary Adoption
13/03/2019
Conference Call Scheduled for Today, Wednesday, March 13, 2019 at 8:30 a.m. ET Highlights: According to MMIT estimates, the authorized generic for APADAZ has unrestricted formulary access for 91% of Commercial lives and [...]
Vaccinex Reports Fourth Quarter 2018 Financial Results and Provides Corporate Update
13/03/2019
Initial data from ongoing open label study of pepinemab (VX15/2503) in combination with avelumab in non-small cell lung cancer expected in 2Q 2019 Enrollment in cohort B of the Phase 2 SIGNAL Huntington’s disease trial [...]
Assembly Biosciences to Participate in the Jefferies 2019 HBV Summit
13/03/2019
SAN FRANCISCO, March 13, 2019 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases [...]
Anavex Life Sciences to Present at the 31st Annual ROTH Conference 2019
13/03/2019
NEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]
SunGen Pharma and Athenex Pharmaceutical Division Announce Busulfan Injection Product Launch
13/03/2019
PRINCETON, N.J., March 13, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced the [...]
ContraFect to Present at the Oppenheimer 29th Annual Healthcare Conference
13/03/2019
YONKERS, New York, March 13, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of novel, differentiated biologic therapeutics [...]
Trevena Reports Fourth Quarter and Full Year 2018 Results
13/03/2019
— Company announces submission of oliceridine healthy volunteer study protocol and analysis plan to FDA — — Successful fundraising extends cash runway into 3Q 2020 — Company to host conference call today, March 13, 2019 [...]
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides a Business Update
13/03/2019
XERMELO ® (telotristat ethyl) 2018 U.S. Net Sales Reached $25.0 Million Sotagliflozin in Type 1 Diabetes: March 22 PDUFA Date in U.S., European Commission Decision Expected in Q2 2019 Following Recently-Received [...]
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2018 Results
13/03/2019
Same Store Volume and Revenue Growth, Along with Expanding Margins, Highlight Progress of Strategic Growth Initiatives BRENTWOOD, Tenn., March 13, 2019 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery [...]
Cyclacel to Participate in 31st Annual ROTH Conference March 18-19
13/03/2019
BERKELEY HEIGHTS, N.J., March 13, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing innovative medicines based on [...]
HEXO Corp to acquire Newstrike Brands Ltd.
13/03/2019
With this acquisition, HEXO will add 470,000 sq. ft. in production space when completed, additional public and private retail channels, and a branding relationship with members of The Tragically Hip Over $400 million of [...]
HEXO Corp fera l’acquisition de Newstrike Brands Ltd.
13/03/2019
Avec cette acquisition, HEXO ajoutera 470 000 pieds carrés d'espace de production lorsque complétée, d'autres canaux de vente au détail publics et privés, et une relation d'image de marque avec les membres de The [...]
Fennec Provides Business Update and Announces Fiscal Year 2018 Financial Results
13/03/2019
Initiated rolling New Drug Application to U.S. FDA for PEDMARK TM Secured $12. 5 million debt financing to support a potential commercial launch Strong financial position with $22.8 million in cash and no debt Targeted [...]
Wright Medical Group N.V. Highlights Recent Innovations at the American Academy of Orthopaedic Surgeons (AAOS) 2019 Annual Meeting
13/03/2019
Company to Showcase New REVIVE™ Revision Shoulder System and CARTIVA® Synthetic Cartilage Implant AMSTERDAM, The Netherlands, March 13, 2019 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) today announced [...]
Mesoblast Features at Upcoming U.S. Investor Conferences
13/03/2019
NEW YORK and MELBOURNE, Australia, March 13, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB; Nasdaq: MESO) today announced it will be featured at two investor conferences in March: Oppenheimer 29th Annual [...]

Pages